Peter S Klein Denali Therapeutics Inc. (DNLI) insider trading activity
Peter S Klein is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 21,496 shares of DNLI, which is worth approximately $446,686. The most recent transaction as insider was on May 31, 2024, when has been sold 5,967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21.5K
0%
3M change
38.42%
12M change
Total Value Held
$446,686
Peter S Klein Transaction History
Also insider at
PSK
Peter S Klein
Director
Seattle, WA